;
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Subscription term licenses | $ | 23,904 | $ | 19,364 | $ | 59,089 | $ | 62,949 | |||||||||||||||
Subscription SaaS, support & maintenance | 31,282 | 22,940 | 87,029 | 61,543 | |||||||||||||||||||
Perpetual licenses | 91 | 183 | 197 | 885 | |||||||||||||||||||
Total subscriptions and perpetual licenses | 55,277 | 42,487 | 146,315 | 125,377 | |||||||||||||||||||
Professional services | 2,943 | 1,739 | 7,674 | 3,652 | |||||||||||||||||||
Total revenue | 58,220 | 44,226 | 153,989 | 129,029 | |||||||||||||||||||
Cost of revenue(1): | |||||||||||||||||||||||
Subscriptions and perpetual licenses | 6,635 | 4,517 | 18,903 | 12,312 | |||||||||||||||||||
Professional services | 2,929 | 3,977 | 8,692 | 10,658 | |||||||||||||||||||
Total cost of revenue | 9,564 | 8,494 | 27,595 | 22,970 | |||||||||||||||||||
Gross profit | 48,656 | 35,732 | 126,394 | 106,059 | |||||||||||||||||||
Operating expenses(1): | |||||||||||||||||||||||
Research and development | 15,554 | 10,827 | 45,699 | 31,214 | |||||||||||||||||||
Sales and marketing | 28,973 | 22,509 | 86,001 | 64,795 | |||||||||||||||||||
General and administrative | 14,551 | 11,188 | 43,030 | 28,091 | |||||||||||||||||||
Acquisition-related costs | 2,364 | — | 2,364 | — | |||||||||||||||||||
Total operating expenses | 61,442 | 44,524 | 177,094 | 124,100 | |||||||||||||||||||
Operating loss | (12,786) | (8,792) | (50,700) | (18,041) | |||||||||||||||||||
Foreign currency gain (loss) | 2,173 | (2,684) | 3,634 | (3,003) | |||||||||||||||||||
Fair value adjustment on warrants and preferred stock tranche option | — | (2,729) | — | (10,068) | |||||||||||||||||||
Interest expense | (894) | (1,195) | (2,674) | (3,572) | |||||||||||||||||||
Other income (expense), net | 721 | 339 | 1,065 | (66) | |||||||||||||||||||
Interest and other expense, net | 2,000 | (6,269) | 2,025 | (16,709) | |||||||||||||||||||
Loss before income taxes | (10,786) | (15,061) | (48,675) | (34,750) | |||||||||||||||||||
Provision for income taxes | 152 | 205 | 1,103 | 660 | |||||||||||||||||||
Net loss | $ | (10,938) | $ | (15,266) | $ | (49,778) | $ | (35,410) | |||||||||||||||
Net loss per share attributable to common stockholders: | |||||||||||||||||||||||
Basic and diluted | $ | (0.13) | $ | (0.44) | $ | (0.59) | $ | (1.26) | |||||||||||||||
Weighted-average shares used in computing net loss per share attributable to common stockholders: | |||||||||||||||||||||||
Basic and diluted | 85,085 | 34,680 | 84,488 | 28,124 | |||||||||||||||||||
¹ Includes stock-based compensation as follows (in thousands): | |||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Cost of revenue | $ | 657 | $ | 26 | $ | 1,789 | $ | 193 | |||||||||||||||
Research and development | 1,632 | 564 | 4,685 | 1,058 | |||||||||||||||||||
Sales and marketing | 2,798 | 1,078 | 7,859 | 2,046 | |||||||||||||||||||
General and administrative | 2,638 | 1,441 | 7,822 | 3,099 | |||||||||||||||||||
Total stock-based compensation expense | $ | 7,725 | $ | 3,109 | $ | 22,155 | $ | 6,396 |
September 30, 2022 | December 31, 2021 | ||||||||||
Assets | |||||||||||
Cash and cash equivalents | $ | 138,542 | $ | 128,381 | |||||||
Short-term investments | 203,971 | 241,411 | |||||||||
Accounts receivable, net of allowance for credit losses of $155 and $34, respectively | 33,307 | 55,999 | |||||||||
Contract assets | 22,778 | 19,670 | |||||||||
Deferred commissions | 8,697 | 8,457 | |||||||||
Prepaid expenses and other assets | 12,899 | 9,787 | |||||||||
Total current assets | 420,194 | 463,705 | |||||||||
Deferred commissions | 17,891 | 15,601 | |||||||||
Property and equipment, net | 2,800 | 2,463 | |||||||||
Operating lease right-of-use assets | 10,272 | 12,626 | |||||||||
Contract and other assets | 3,495 | 2,783 | |||||||||
Total assets | $ | 454,652 | $ | 497,178 | |||||||
Liabilities and stockholders’ equity | |||||||||||
Accounts payable | $ | 1,511 | $ | 2,039 | |||||||
Accrued compensation | 19,214 | 22,359 | |||||||||
Accrued expenses | 8,961 | 5,016 | |||||||||
Current portion of operating lease liability | 1,562 | 1,820 | |||||||||
Deferred revenue | 57,923 | 67,222 | |||||||||
Other liabilities | 1,331 | 2,258 | |||||||||
Total current liabilities | 90,502 | 100,714 | |||||||||
Long-term debt | 39,579 | 39,483 | |||||||||
Long-term operating lease liability | 9,519 | 11,037 | |||||||||
Deferred revenue | 1,377 | 8,172 | |||||||||
Other liabilities | 1,909 | 1,646 | |||||||||
Total liabilities | 142,886 | 161,052 | |||||||||
Stockholders’ equity: | |||||||||||
Common stock | 85 | 83 | |||||||||
Additional paid-in capital | 623,671 | 593,196 | |||||||||
Accumulated other comprehensive income | 1,613 | 6,672 | |||||||||
Accumulated deficit | (313,603) | (263,825) | |||||||||
Total stockholders’ equity | 311,766 | 336,126 | |||||||||
Total liabilities and stockholders’ equity | $ | 454,652 | $ | 497,178 | |||||||
As of October 31, 2022, there were 47,666,366 shares of the registrant's Class A common stock outstanding and 37,692,159 shares of the registrant's Class B common stock outstanding. |
Nine Months Ended September 30, | |||||||||||
2022 | 2021 | ||||||||||
Operating activities: | |||||||||||
Net loss | $ | (49,778) | $ | (35,410) | |||||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
Depreciation | 812 | 795 | |||||||||
Noncash operating lease expense | 1,865 | 1,186 | |||||||||
Stock-based compensation expense | 22,155 | 6,396 | |||||||||
Amortization of deferred commissions | 10,652 | 10,436 | |||||||||
Foreign currency remeasurement (loss) gain | (3,636) | 1,972 | |||||||||
Change in fair value of redeemable convertible preferred stock warrant liability | — | 5,871 | |||||||||
Change in fair value of preferred stock tranche option liability | — | 4,157 | |||||||||
Amortization of premium / discount on short-term investments | 1,690 | 608 | |||||||||
Other | 28 | 157 | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Deferred commissions | (13,182) | (14,366) | |||||||||
Accounts receivable | 22,094 | (2,170) | |||||||||
Contract and other non-current assets | (3,416) | (13,500) | |||||||||
Prepaid expenses and other current assets | (3,291) | (3,696) | |||||||||
Operating lease liabilities | (1,301) | (1,614) | |||||||||
Accounts payable | (506) | 272 | |||||||||
Accrued expenses and other liabilities | 509 | 3,244 | |||||||||
Deferred revenue | (15,699) | 4,306 | |||||||||
Net cash used in operating activities | (31,004) | (31,356) | |||||||||
Investing activities: | |||||||||||
Purchases of property and equipment | (1,474) | (459) | |||||||||
Purchases of short-term investments | (139,149) | (201,415) | |||||||||
Maturities of short-term investments | 133,615 | — | |||||||||
Sales of short-term investments | 39,110 | 19,960 | |||||||||
Net cash provided by (used in) investing activities | 32,102 | (181,914) | |||||||||
Financing activities: | |||||||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | — | 295,694 | |||||||||
Payment of offering costs | (145) | (4,076) | |||||||||
Proceeds from exercises of employee stock options | 4,150 | 3,189 | |||||||||
Proceeds from issuance of common stock under employee stock purchase plan | 4,374 | — | |||||||||
Employee payroll taxes paid for net shares settlement of restricted stock units | (188) | (3,528) | |||||||||
Proceeds from issuance of redeemable convertible preferred stock | — | 19,951 | |||||||||
Principal repayments on debt | — | (120) | |||||||||
Net cash provided by financing activities | 8,191 | 311,110 | |||||||||
Effect of exchange rates on cash and cash equivalents and restricted cash | 857 | (638) | |||||||||
Net increase in cash, cash equivalents and restricted cash | 10,146 | 97,202 | |||||||||
Cash, cash equivalents and restricted cash, beginning of year | 128,437 | 100,042 | |||||||||
Cash, cash equivalents and restricted cash, end of period | $ | 138,583 | $ | 197,244 | |||||||
Reconciliation of cash and cash equivalents and restricted cash: | |||||||||||
Cash and cash equivalents | $ | 138,542 | $ | 197,221 | |||||||
Restricted cash included in prepaids and other current assets | 41 | 23 | |||||||||
Total cash and cash equivalents and restricted cash | $ | 138,583 | $ | 197,244 | |||||||
Short-term investments, end of period | $ | 203,971 | $ | 180,872 |
Non-GAAP Gross Profit and Non-GAAP Gross Margin | |||||||||||||||||||||||
Gross profit is defined as GAAP revenue less cost of revenue and gross margin is GAAP gross profit as a percentage of total revenue. We define non-GAAP gross profit and non-GAAP gross margin as GAAP gross profit and GAAP gross margin adjusted to exclude stock-based compensation expense, as presented below (in thousands, except percentages): | |||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Gross Profit | $ | 48,656 | $ | 35,732 | $ | 126,394 | $ | 106,059 | |||||||||||||||
Add: Stock-based compensation included in cost of revenue | 657 | 26 | 1,789 | 193 | |||||||||||||||||||
Non-GAAP gross profit | $ | 49,313 | $ | 35,758 | $ | 128,183 | $ | 106,252 | |||||||||||||||
Gross margin | 84 | % | 81 | % | 82 | % | 82 | % | |||||||||||||||
Non-GAAP gross margin | 85 | % | 81 | % | 83 | % | 82 | % | |||||||||||||||
Non-GAAP Research and Development | |||||||||||||||||||||||
We define non-GAAP research and development as GAAP research and development adjusted to exclude stock-based compensation expense, as presented below (in thousands): | |||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Research and development | $ | 15,554 | $ | 10,827 | $ | 45,699 | $ | 31,214 | |||||||||||||||
Less: Stock-based compensation | 1,632 | 564 | 4,685 | 1,058 | |||||||||||||||||||
Non-GAAP research and development | $ | 13,922 | $ | 10,263 | $ | 41,014 | $ | 30,156 | |||||||||||||||
Non-GAAP Sales and Marketing | |||||||||||||||||||||||
We define non-GAAP sales and marketing as GAAP sales and marketing adjusted to exclude stock-based compensation expense, as presented below (in thousands): | |||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Sales and marketing | $ | 28,973 | $ | 22,509 | $ | 86,001 | $ | 64,795 | |||||||||||||||
Less: Stock-based compensation | 2,798 | 1,078 | 7,859 | 2,046 | |||||||||||||||||||
Non-GAAP sales and marketing | $ | 26,175 | $ | 21,431 | $ | 78,142 | $ | 62,749 | |||||||||||||||
Non-GAAP General and Administrative | |||||||||||||||||||||||
We define non-GAAP general and administrative as GAAP general and administrative adjusted to exclude stock-based compensation expense, as presented below (in thousands): | |||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
General and administrative | $ | 14,551 | $ | 11,188 | $ | 43,030 | $ | 28,091 | |||||||||||||||
Less: Stock-based compensation | 2,638 | 1,441 | 7,822 | 3,099 | |||||||||||||||||||
Non-GAAP general and administrative | $ | 11,913 | $ | 9,747 | $ | 35,208 | $ | 24,992 | |||||||||||||||
Non-GAAP Operating Loss and Non-GAAP Operating Margin | |||||||||||||||||||||||
We define non-GAAP operating loss and non-GAAP operating margin as GAAP operating loss and GAAP operating margin adjusted to exclude stock-based compensation expense and acquisition-related costs, as presented below (in thousands, except percentages): | |||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Operating loss | $ | (12,786) | $ | (8,792) | $ | (50,700) | $ | (18,041) | |||||||||||||||
Add: Stock-based compensation | 7,725 | 3,109 | 22,155 | 6,396 | |||||||||||||||||||
Add: Acquisition-related costs | 2,364 | — | 2,364 | — | |||||||||||||||||||
Non-GAAP operating loss | $ | (2,697) | $ | (5,683) | $ | (26,181) | $ | (11,645) | |||||||||||||||
Operating margin | (22) | % | (20) | % | (33) | % | (14) | % | |||||||||||||||
Non-GAAP operating margin | (5) | % | (13) | % | (17) | % | (9) | % | |||||||||||||||
Adjusted EBITDA | |||||||||||||||||||||||
We define adjusted EBITDA as operating loss adjusted to exclude depreciation, stock-based compensation expense and acquisition-related costs, as presented below (in thousands): | |||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Operating loss | $ | (12,786) | $ | (8,792) | $ | (50,700) | $ | (18,041) | |||||||||||||||
Add: Depreciation | 263 | 259 | 812 | 795 | |||||||||||||||||||
Add: Stock-based compensation | 7,725 | 3,109 | 22,155 | 6,396 | |||||||||||||||||||
Add: Acquisition-related costs | 2,364 | — | 2,364 | — | |||||||||||||||||||
Adjusted EBITDA | $ | (2,434) | $ | (5,424) | $ | (25,369) | $ | (10,850) | |||||||||||||||
Non-GAAP Net Loss and Non-GAAP Net Loss per Share, Basic and Diluted | |||||||||||||||||||||||
We define non-GAAP net loss as GAAP net loss adjusted to exclude stock-based compensation expense and acquisition-related costs, including the tax effect of stock-based compensation expense on the provision for (benefit from) income taxes as presented below (in thousands, except per share amounts): | |||||||||||||||||||||||
We define non-GAAP net loss per share, basic, as non-GAAP net loss divided by GAAP weighted-average shares used to compute net loss per share, basic. | |||||||||||||||||||||||
We define non-GAAP net loss per share, diluted, as non-GAAP net loss divided by GAAP weighted average shares used to compute net loss per share, basic, adjusted for (i) the dilutive effect of employee equity awards, excluding the impact of unrecognized stock-based compensation expense and (ii) warrants; unless these adjustments are anti-dilutive. | |||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Net loss | $ | (10,938) | $ | (15,266) | $ | (49,778) | $ | (35,410) | |||||||||||||||
Add: Stock-based compensation | 7,725 | 3,109 | 22,155 | 6,396 | |||||||||||||||||||
Add: Acquisition-related costs | 2,364 | — | 2,364 | — | |||||||||||||||||||
Tax effect on the provision for income taxes | (65) | (14) | (198) | (37) | |||||||||||||||||||
Non-GAAP net loss | $ | (914) | $ | (12,171) | $ | (25,457) | $ | (29,051) | |||||||||||||||
Non-GAAP net loss per share, basic and diluted | $ | (0.01) | $ | (0.35) | $ | (0.30) | $ | (1.03) | |||||||||||||||
Free Cash Flow | |||||||||||||||||||||||
We define free cash flow as net cash provided by (used in) operating activities less cash used for purchases of property and equipment as presented below (in thousands): | |||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Net cash used in operating activities | $ | (4,580) | $ | (2,035) | $ | (31,004) | $ | (31,356) | |||||||||||||||
Purchases of property and equipment | (500) | (118) | (1,474) | (459) | |||||||||||||||||||
Free cash flow | $ | (5,080) | $ | (2,153) | $ | (32,478) | $ | (31,815) | |||||||||||||||